Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.174 EUR
73.45 M EUR
973.88 M EUR
547.64 M
About FISHER & PAYKEL HEALTHCARE CORP NPV
Sector
Industry
CEO
Lewis George Gradon
Website
Headquarters
Auckland
Founded
1934
ISIN
NZFAPE0001S2
FIGI
BBG000CPR2Z8
Fisher & Paykel Healthcare Corp. Ltd. engages in the design, manufacture, and marketing of products and systems for use in acute and chronic respiratory care, surgery, and treatment of obstructive sleep apnea. It operates through the following geographical segments: North America, Europe, Asia Pacific, and Other. The Other segment includes New Zealand, Latin America, Africa, and the Middle East. The company was founded in 1969 and is headquartered in Auckland, New Zealand.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Fisher & Paykel Health Corp. Ltd. stocks are traded under the ticker FPLB.
We've gathered analysts' opinions on Fisher & Paykel Health Corp. Ltd. future price: according to them, FPLB price has a max estimate of 22.97 EUR and a min estimate of 13.33 EUR. Watch FPLB chart and read a more detailed Fisher & Paykel Health Corp. Ltd. stock forecast: see what analysts think of Fisher & Paykel Health Corp. Ltd. and suggest that you do with its stocks.
FPLB reached its all-time high on Dec 2, 2024 with the price of 22.200 EUR, and its all-time low was 5.290 EUR and was reached on Nov 23, 2016. View more price dynamics on FPLB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Fisher & Paykel Health Corp. Ltd. financials in yearly and quarterly reports right on TradingView.
Fisher & Paykel Health Corp. Ltd. is going to release the next earnings report on May 21, 2025. Keep track of upcoming events with our Earnings Calendar.
FPLB earnings for the last half-year are 0.15 EUR per share, whereas the estimation was 0.15 EUR, resulting in a −2.72% surprise. The estimated earnings for the next half-year are 0.18 EUR per share. See more details about Fisher & Paykel Health Corp. Ltd. earnings.
Fisher & Paykel Health Corp. Ltd. revenue for the last half-year amounts to 541.99 M EUR, despite the estimated figure of 538.69 M EUR. In the next half-year revenue is expected to reach 567.53 M EUR.
FPLB net income for the last half-year is 87.29 M EUR, while the previous report showed 14.01 M EUR of net income which accounts for 522.87% change. Track more Fisher & Paykel Health Corp. Ltd. financial stats to get the full picture.
Fisher & Paykel Health Corp. Ltd. dividend yield was 1.90% in 2023, and payout ratio reached 214.33%. The year before the numbers were 1.79% and 110.06% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 7.14 K employees. See our rating of the largest employees — is Fisher & Paykel Health Corp. Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Fisher & Paykel Health Corp. Ltd. EBITDA is 309.06 M EUR, and current EBITDA margin is 27.47%. See more stats in Fisher & Paykel Health Corp. Ltd. financial statements.
Like other stocks, FPLB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Fisher & Paykel Health Corp. Ltd. stock right from TradingView charts — choose your broker and connect to your account.